个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
12只医疗保健类股在周三的盘中交易时段走势
Gainers
- Venus Concept (NASDAQ:VERO) shares increased by 61.1% to $0.41 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is 66.0 million, which is 11325.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $28.1 million.
- Bellerophon Therapeutics (NASDAQ:BLPH) shares increased by 38.04% to $0.93. The company's market cap stands at $8.8 million.
- F-star Therapeutics (NASDAQ:FSTX) shares increased by 29.16% to $5.58. As of 12:30 EST, F-star Therapeutics's stock is trading at a volume of 1.6 million, which is 811.7% of its average full-day volume over the last 100 days. The company's market cap stands at $122.6 million.
- Kineta (NASDAQ:KA) shares rose 26.84% to $4.76. As of 12:30 EST, this security is trading at a volume of 135.9K shares, making up 37.0% of its average full-day volume over the last 100 days. The company's market cap stands at $370.2 million.
- The Oncology Institute (NASDAQ:TOI) shares rose 23.18% to $1.19. The current volume of 239.9K shares is 134.8% of The Oncology Institute's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $86.0 million.
- Verona Pharma (NASDAQ:VRNA) shares rose 22.64% to $22.8. As of 12:30 EST, this security is trading at a volume of 3.4 million shares, making up 650.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.7 billion.
Losers
- Celyad Oncology (NASDAQ:CYAD) shares fell 37.8% to $0.65 during Wednesday's regular session. Celyad Oncology's stock is trading at a volume of 113.1K shares as of 12:30 EST. This is 2339.9% of its average full-day volume over the last 100 days. The company's market cap stands at $14.7 million.
- Quotient (NASDAQ:QTNT) stock fell 22.48% to $0.22. As of 12:30 EST, this security is trading at a volume of 493.3K shares, making up 204.8% of its average full-day volume over the last 100 days.
- Tivic Health Systems (NASDAQ:TIVC) shares fell 15.64% to $0.7. Trading volume for this security as of 12:30 EST is 84.4K, which is 190.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.7 million.
- ProSomnus (NASDAQ:OSA) shares fell 15.23% to $5.01. The market value of their outstanding shares is at $77.5 million.
- Processa Pharma (NASDAQ:PCSA) stock declined by 14.38% to $1.31. Processa Pharma's stock is trading at a volume of 83.2K shares as of 12:30 EST. This is 255.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.9 million.
- Lucira Health (NASDAQ:LHDX) shares fell 14.37% to $0.15. Trading volume for Lucira Health's stock is 365.4K as of 12:30 EST. This is 214.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.2 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Gainers
赢家
- Venus Concept (NASDAQ:VERO) shares increased by 61.1% to $0.41 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is 66.0 million, which is 11325.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $28.1 million.
- Bellerophon Therapeutics (NASDAQ:BLPH) shares increased by 38.04% to $0.93. The company's market cap stands at $8.8 million.
- F-star Therapeutics (NASDAQ:FSTX) shares increased by 29.16% to $5.58. As of 12:30 EST, F-star Therapeutics's stock is trading at a volume of 1.6 million, which is 811.7% of its average full-day volume over the last 100 days. The company's market cap stands at $122.6 million.
- Kineta (NASDAQ:KA) shares rose 26.84% to $4.76. As of 12:30 EST, this security is trading at a volume of 135.9K shares, making up 37.0% of its average full-day volume over the last 100 days. The company's market cap stands at $370.2 million.
- The Oncology Institute (NASDAQ:TOI) shares rose 23.18% to $1.19. The current volume of 239.9K shares is 134.8% of The Oncology Institute's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $86.0 million.
- Verona Pharma (NASDAQ:VRNA) shares rose 22.64% to $22.8. As of 12:30 EST, this security is trading at a volume of 3.4 million shares, making up 650.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.7 billion.
- 金星概念在周三的例会上,纳斯达克(Sequoia Capital:VERO)股价上涨61.1%,至0.41美元。截至美国东部时间12:30,该证券成交量为6,600万口,是过去100日全天平均成交量的11325.3。他们流通股的市值为2,810万美元。
- 贝勒罗芬治疗公司纳斯达克(Sequoia Capital:BLPH)股价上涨38.04%,至0.93美元。该公司的市值为880万美元。
- F-STAR治疗公司纳斯达克(Tmall:FSTX)股价上涨29.16%,至5.58美元。截至美国东部时间12:30,F-STAR Treateutics的股票成交量为160万股,是过去100日平均全天成交量的811.7%。该公司的市值为1.226亿美元。
- Kineta纳斯达克(Tmall:KA)股价上涨26.84%,至4.76美元。截至美国东部时间12:30,该证券成交量为135.9K股,占其过去100天全天平均成交量的37.0%。该公司的市值为3.702亿美元。
- 肿瘤学研究所纳斯达克股票代码:TOI)股价上涨23.18%,至1.19美元。目前239.9K股的成交量是肿瘤研究所过去100日平均全天成交量的134.8%(最近一次更新是在美国东部时间12:30)。该公司的市值为8,600万美元。
- 维罗纳制药纳斯达克(Youku)股价上涨22.64%,至22.8美元。截至美国东部时间12:30,该证券成交量为340万股,占其过去100日全天平均成交量的650.2。他们流通股的市值为17亿美元。
Losers
失败者
- Celyad Oncology (NASDAQ:CYAD) shares fell 37.8% to $0.65 during Wednesday's regular session. Celyad Oncology's stock is trading at a volume of 113.1K shares as of 12:30 EST. This is 2339.9% of its average full-day volume over the last 100 days. The company's market cap stands at $14.7 million.
- Quotient (NASDAQ:QTNT) stock fell 22.48% to $0.22. As of 12:30 EST, this security is trading at a volume of 493.3K shares, making up 204.8% of its average full-day volume over the last 100 days.
- Tivic Health Systems (NASDAQ:TIVC) shares fell 15.64% to $0.7. Trading volume for this security as of 12:30 EST is 84.4K, which is 190.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.7 million.
- ProSomnus (NASDAQ:OSA) shares fell 15.23% to $5.01. The market value of their outstanding shares is at $77.5 million.
- Processa Pharma (NASDAQ:PCSA) stock declined by 14.38% to $1.31. Processa Pharma's stock is trading at a volume of 83.2K shares as of 12:30 EST. This is 255.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.9 million.
- Lucira Health (NASDAQ:LHDX) shares fell 14.37% to $0.15. Trading volume for Lucira Health's stock is 365.4K as of 12:30 EST. This is 214.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.2 million. See Also:
- 塞利亚德肿瘤学在周三的例行交易中,纳斯达克(Sequoia Capital:CYAD)股价下跌37.8%,至0.65美元。截至美国东部时间12:30,Celyad Oncology的股票交易量为113.1K股。这是过去100日平均全天成交量的2339.9%。该公司的市值为1,470万美元。
- 商纳斯达克股票代码:QTNT)股价下跌22.48%,至0.22美元。截至美国东部时间12:30,该证券成交量为493.3K股,占其过去100日全天平均成交量的204.8。
- Tivic Health Systems纳斯达克(Standard Chartered Bank:TIVC)股价下跌15.64%,至0.7美元。截至美国东部时间12:30,该证券的成交量为84.4K,是过去100日全天平均成交量的190.0。他们流通股的市值为670万美元。
- 普罗索姆努斯纳斯达克(Tmall:OSA)股价下跌15.23%,至5.01美元。他们流通股的市值为7,750万美元。
- Processa制药纳斯达克(Sequoia Capital:PCSA)股价下跌14.38%至1.31美元。截至美国东部时间12:30,Processa Pharma的股票交易量为83.2万股。这是过去100日平均全天成交量的255.4%。他们流通股的市值为2,090万美元。
- Lucira Health纳斯达克(Tmall:LHDX)股价下跌14.37%,至0.15美元。截至美国东部时间12:30,Lucira Health的股票成交量为365.4K。这是过去100日平均全天成交量的214.1%。他们流通股的市值为620万美元。另见:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!